Clearside Biomedical, Inc. Common Stock (CLSD) Revenue (2016 - 2025)
Clearside Biomedical, Inc. Common Stock (CLSD) revenue from Jun 30, 2016 to Sep 30, 2025. The TTM Clearside Biomedical, Inc. Common Stock (CLSD) revenue is $3.33M. You can adjust inflation or export chart.
Annual Revenue
Quarterly Revenue
Clearside Biomedical, Inc. Common Stock (CLSD) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -56.81% |
| 3 Years TTM | -50.03% |
| 5 Years TTM | -19.45% |
| All Time TTM | +44.46% |
Annual Revenue change of Clearside Biomedical, Inc. Common Stock (CLSD)
| Year | Revenue | Change |
|---|---|---|
| 2025 | $3.02M | +81.93% |
| 2024 | $1.66M | -79.83% |
| 2023 | $8.23M | +518.80% |
| 2022 | $1.33M | -95.50% |
| 2021 | $30M | +274.90% |
| 2020 | $7.89M | +263.59% |
| 2019 | $2.17M | +7133.33% |
| 2018 | $30K | -91.43% |
| 2017 | $350K | -32.69% |
| 2016 | $520K | N/A |
Comparison Clearside Biomedical, Inc. Common Stock (CLSD) five years revenue CAGR with competitors
Clearside Biomedical, Inc. Common Stock (CLSD) five years revenue CAGR is -19.46%.